Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CVS Will Retain $300M In Drug Rebates In 2018, PBM Says

Aug 09 2018

• By Cathy Kelly

US dollars and pills

Related Content

CVS/Aetna To Merge In Defensive Play To Reshape Healthcare Delivery

Dec 04 2017

HHS Advancing Attack On Rebates With Proposal To Revoke Safe Harbor

Jul 25 2018

Step Therapy For Medicare Part B Drugs Will Lower Costs By 20%, HHS Projects

Aug 09 2018

Related Companies

CVS Health Corp.

Additional Topics

United States Pricing Debate Policy BioPharmaceutical

More from Pricing Debate

More from Market Access

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window